The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of FibroGen Inc (NASDAQ: FGEN) closed at $0.27 in the last session, down -2.46% from day before closing price of $0.28. In other words, the price has decreased by -$2.46 from its previous closing price. On the day, 1.22 million shares were traded. FGEN stock price reached its highest trading level at $0.28 during the session, while it also had its lowest trading level at $0.2498.
Ratios:
We take a closer look at FGEN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.45 and its Current Ratio is at 1.47.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 24 ’25 when Wettig Thane bought 145,000 shares for $0.35 per share. The transaction valued at 50,663 led to the insider holds 543,329 shares of the business.
Schoeneck James A bought 250,000 shares of FGEN for $88,000 on Mar 20 ’25. The Director now owns 323,722 shares after completing the transaction at $0.35 per share. On Mar 21 ’25, another insider, Schoeneck James A, who serves as the Director of the company, bought 50,000 shares for $0.34 each. As a result, the insider paid 17,040 and bolstered with 373,722 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FGEN now has a Market Capitalization of 27560432 and an Enterprise Value of 109915744. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.18. Its current Enterprise Value per Revenue stands at 3.711 whereas that against EBITDA is -0.857.
Stock Price History:
The Beta on a monthly basis for FGEN is 0.87, which has changed by -0.8192053 over the last 52 weeks, in comparison to a change of -0.028342128 over the same period for the S&P500. Over the past 52 weeks, FGEN has reached a high of $1.74, while it has fallen to a 52-week low of $0.18. The 50-Day Moving Average of the stock is -36.93%, while the 200-Day Moving Average is calculated to be -45.50%.
Shares Statistics:
According to the various share statistics, FGEN traded on average about 3.49M shares per day over the past 3-months and 1305980 shares per day over the past 10 days. A total of 100.92M shares are outstanding, with a floating share count of 93.96M. Insiders hold about 6.90% of the company’s shares, while institutions hold 36.10% stake in the company. Shares short for FGEN as of 1741910400 were 4978990 with a Short Ratio of 1.43, compared to 1739491200 on 2946557. Therefore, it implies a Short% of Shares Outstanding of 4978990 and a Short% of Float of 5.8000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
